Home » Stocks » RACA

Therapeutics Acquisition Corp. (RACA)

Stock Price: $10.03 USD 0.04 (0.40%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
After-hours: $9.50 -0.53 (-5.28%) Apr 16, 5:46 PM
Market Cap 179.23M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 14.04M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $10.03
Previous Close $9.99
Change ($) 0.04
Change (%) 0.40%
Day's Open 10.04
Day's Range 9.98 - 10.10
Day's Volume 587,319
52-Week Range 9.91 - 21.44


Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Australis Capital Inc (CSE:AUSA) (OTC:AUSAF) (FRA:AC4) announced Wednesday that it has completed the first stage of its previously announced acquisition of Nevada cannabis company Green Therapeutics LLC...

Other stocks mentioned: AUSAF, TXAC
3 weeks ago - Proactive Investors

Takeda Pharmaceutical Co Ltd (NYSE: TAK) has exercised the option to acquire Maverick Therapeutics, following an agreement signed in 2017, in which Takeda received an equity stake and an exclusive right...

Other stocks mentioned: TAK, TXAC
1 month ago - Benzinga

These shell companies allow the businesses they acquire to go public much more quickly than an IPO would. Is it time to buy in?

Other stocks mentioned: INVA, JAZZ, TBPH, TXAC, TXG
7 months ago - The Motley Fool

Forget traditional IPOs! This blank check vehicle is proving to be an effective tool for biotech companies to raise capital.

Other stocks mentioned: IMVT, PHGE, TXAC
8 months ago - The Motley Fool

BOSTON--(BUSINESS WIRE)--Therapeutics Acquisition Corp. (Nasdaq: TXAC) (the u201cCompanyu201d) announced today that on July 10, 2020 it closed its initial public offering of 13,570,000 shares of Class A...

Other stocks mentioned: TXAC
9 months ago - Business Wire

The special purpose acquisition company is sponsored by RA Capital Management.

Other stocks mentioned: TXAC
9 months ago - The Motley Fool

About RACA

Therapeutics Acquisition Corp., doing business as Research Alliance Corp. I, does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry in the United States. The company was incorporated in 2020 and is based in Boston, Massachusetts.

Shell Companies
IPO Date
Jul 8, 2020
Stock Exchange
Ticker Symbol
Full Company Profile